Creative Medical Technology Holdings Inc
NASDAQ:CELZ

Watchlist Manager
Creative Medical Technology Holdings Inc Logo
Creative Medical Technology Holdings Inc
NASDAQ:CELZ
Watchlist
Price: 2.08 USD -0.95% Market Closed
Market Cap: $5.4m

Net Margin

-99 356.7%
Current
Declining
by 55 021%
vs 3-y average of -44 335.7%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-99 356.7%
=
Net Income
$-6m
/
Revenue
$6k

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-99 356.7%
=
Net Income
$-6m
/
Revenue
$6k

Peer Comparison

Country Company Market Cap Net
Margin
US
Creative Medical Technology Holdings Inc
NASDAQ:CELZ
5.4m USD
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Abbvie Inc
NYSE:ABBV
394.7B USD
Loading...
US
Amgen Inc
NASDAQ:AMGN
187.9B USD
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
175B USD
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
120.2B USD
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
80.6B USD
Loading...
AU
CSL Ltd
ASX:CSL
87.1B AUD
Loading...
NL
argenx SE
XBRU:ARGX
44.1B EUR
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
47.5B USD
Loading...

Market Distribution

Lower than 99% of companies in the United States of America
Percentile
1st
Based on 15 072 companies
1st percentile
-99 356.7%
Low
-4 418 600% — -9.6%
Typical Range
-9.6% — 11.3%
High
11.3% — 1 135 400%
Distribution Statistics
the United States of America
Min -4 418 600%
30th Percentile -9.6%
Median 3.1%
70th Percentile 11.3%
Max 1 135 400%

Creative Medical Technology Holdings Inc
Glance View

Market Cap
5.4m USD
Industry
Biotechnology

Creative Medical Technologies, Inc. develops novel regenerative medicine and stem cell technologies. The company is headquartered in Phoenix, Arizona. The company went IPO on 2009-05-01. The firm conducts its commercial operations through its subsidiary, Creative Medical Technologies, Inc. (CMT). CMT markets and sells its CaverStem and FemCelz disposable kits utilized by physicians to perform autologous procedures that treat erectile dysfunction and female sexual dysfunction and female sexual dysfunction, respectively. The firm's products include CaverStem, FemCelz, StemSpine, Amniostem, ImmCelz and OvaStem. CaverStem utilizes a patient's own stem cells to treat erectile dysfunction (ED). FemCelz is used for the treatment and procedure for vaginal rejuvenation function.

CELZ Intrinsic Value
Not Available
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-99 356.7%
=
Net Income
$-6m
/
Revenue
$6k
What is Creative Medical Technology Holdings Inc's current Net Margin?

The current Net Margin for Creative Medical Technology Holdings Inc is -99 356.7%, which is below its 3-year median of -44 335.7%.

How has Net Margin changed over time?

Over the last 3 years, Creative Medical Technology Holdings Inc’s Net Margin has decreased from -5 200% to -99 356.7%. During this period, it reached a low of -99 356.7% on Sep 30, 2025 and a high of -5 200% on Sep 30, 2022.

Back to Top